Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanopartz is a private U.S. nanomaterials company that develops and sells gold nanoparticle products and related functionalization technologies for research use. Its catalog includes spherical gold nanoparticles, gold nanorods, nanowires, nanocubes, nanostars, Raman probes, plasmonic fluorophores, magnetic/plasmonic nanoparticles, and custom biofunctionalized constructs. The company positions its materials for applications across life sciences, including diagnostics, imaging, drug delivery, cell uptake, and therapeutic research, while also serving non-health markets such as sensors, optics, electronics, and energy. Nanopartz appears to operate primarily as a commercial research tools and nanotechnology platform company rather than as a clinical-stage therapeutic developer. Its core differentiators are proprietary methods for controlling nanoparticle size, shape, monodispersity, scale-up, and surface chemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanopartz.